Bravrr develops wearable diagnostic and therapeutic solutions for clinicians and their patients.
Bravrr's first product, BruxRelief, is poised to disrupt the over $9B market of bruxism (unconscious teeth grinding) disorder. 1 in 3 people suffer from bruxism disorder, but sadly less than 10% are diagnosed or ever receive treatment. Worse yet, many patient only receive treatment after damage to their teeth has already occurred or they've developed severe jaw / neck pain, headaches, migraines, TMJ or tinnitus. The diagnostic devices that are on the market are vastly too complex and costly. Bravrr's BruxRelief wearable is an easy to use wearable headband that connects to your smartphone and provides analysis of your nightly bruxism behavior and sleeping patterns through and intuitively built app.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
May 24, 2019 | Pre-seed | $280K | 1 | HAX | — | Detail |